Amgen’s new drug could be a blockbuster
By Jorge Mercado / Friday, June 4th, 2021 / Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, right, Subscriber content, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies / Comments Off on Amgen’s new drug could be a blockbuster
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →‘A big change’ on the way as some companies continue remote work
By Jorge Mercado / Friday, June 4th, 2021 / Central Coast, East Ventura County, Latest news, Real Estate, South Coast, Subscriber content, Technology, Top Stories, Top Story, Tri-County Economy, West Ventura County / Comments Off on ‘A big change’ on the way as some companies continue remote work
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Amgen reaches billion-dollar licensing deal with Japanese firm
By Staff Report / Wednesday, June 2nd, 2021 / Banking & Finance, Biotech, East Ventura County, Latest news, Tri-County Economy, Tri-County Public Companies / Comments Off on Amgen reaches billion-dollar licensing deal with Japanese firm
Amgen announced an agreement June 1 with Kyowa Kirin, a Japanese pharmaceutical company, to jointly develop and commercialize a human monoclonal antibody that Kyowa Kirin is developing to treat atopic dermatitis and other autoimmune diseases. The deal could be worth $1.25 billion or more. Amgen will led the development, manufacturing and commercialization for the treatment, Read More →
Read More →Amgen gets FDA approval for potential billion-dollar drug
By Jorge Mercado / Friday, May 28th, 2021 / Banking & Finance, Biotech, East Ventura County, Latest news, right, Top Stories, Tri-County Economy, Tri-County Public Companies / Comments Off on Amgen gets FDA approval for potential billion-dollar drug
Thousand Oaks-based Amgen won approval from the U.S. Food and Drug Administration on May 28 for its latest oral drug treatment, Lumakras, potentially adding another huge market for one of the largest biotech firms in the world. According to the Wall Street Journal, Amgen will charge $17,900 a month for the drug and analyst think Read More →
Read More →Direct Relief comes to India’s aid during COVID crisis
By Jorge Mercado / Friday, May 14th, 2021 / Central Coast Health Watch, Latest news, middle, Nonprofits, Subscriber content, Top Stories / Comments Off on Direct Relief comes to India’s aid during COVID crisis
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Amgen planning apartments on its land in Thousand Oaks
By Amber Hair / Friday, May 7th, 2021 / Biotech, East Ventura County, Latest news, Real Estate, Subscriber content, Top Stories, Tri-County Economy / Comments Off on Amgen planning apartments on its land in Thousand Oaks
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Amgen CEO again tops list of region’s highest paid execs
By Amber Hair / Friday, April 30th, 2021 / Banking & Finance, Latest news, Top Stories, Tri-County Public Companies / Comments Off on Amgen CEO again tops list of region’s highest paid execs
Robert Bradway remained the highest paid executive in the Tri-Counties in 2020, but stock options and new faces changed a lot of the names and positions on the list. Bradway, the CEO of Amgen, earned $20.13 million in total compensation in 2020 — 3% more than he earned in 2019, and 8.23% more than in Read More →
Read More →Popular articles
- None Found
Sponsored content:
SHIPS SLOW TO PROTECT WHALES, BLUE SKIES
-
Sign up for email news
Get the Business Times in your inbox. Sign up for breaking news alerts, our weekly briefing, and more.Sign upFor Email Marketing you can trust.2015-2016 Giving Guide
Check out our 2015 Giving Guide special issue